INTRODUCTION
One of the issues which requires careful consideration in contractual litigation is the intersection between the law of prescription and agreements concluded subject to suspensive conditions. Specifically, the issue of whether prescription commences to run from the date on which the agreement is signed, or only from the date upon which the suspensive condition is fulfilled.
The Supreme Court of Appeal (“SCA”), in its recent judgment of Tight Business Enterprise CC v Petrus Johannes Lordan NO & Others (356/24) [2025] ZASCA 133
(“Tight Business Enterprise”) handed down on 17 September 2025, provided much- needed clarity. The decision offers important clarity not only for litigants but also for transactional lawyers who regularly draft and enforce agreements containing suspensive conditions.
THE FACTS OF TIGHT BUSINESS ENTERPRISE
On 5 January 2009, the Johan Lordan Trust (“Trust”) sold immovable property to Tight Business Enterprises (“TBE”). The sale agreement contained a suspensive condition that by 30 June 2009, the Minister of Agriculture was required to consent to the subdivision and separate transfer of the immovable property. TBE alleged that consent was obtained on 4 June 2009.
Relying on the sale agreement, TBE instituted an action for specific performance against the Trust on 6 March 2021. The trustees of the Trust raised a special plea of prescription, arguing that the debt became due on 5 January 2009, being the signature date of the sale agreement, and thus prescribed on 4 January 2012.
The High Court dismissed the special plea, holding that prescription only began to run upon fulfilment of the suspensive condition. On appeal, however, the full court of the High Court overturned the decision, finding that prescription ran from the date of signature of the sale agreement. TBE then appealed to the SCA.
PRINCIPLES OF SUSPENSIVE CONDITIONS AND PRESCRIPTION
Before turning to the SCA’s findings, it is necessary to revisit the general principles of contract law governing suspensive conditions, as well as the statutory framework of prescription.
The law of contract recognises that parties may subject agreements to suspensive conditions. A suspensive condition suspends the enforceability of a contractual duty until the occurrence of a specified future uncertain event. Pending the occurrence of that event, the parties are nonetheless bound by a contractual relationship, but their rights and duties remain unenforceable. If the condition is fulfilled, the agreement is perfected and obligations become enforceable; if the condition fails, the agreement typically lapses, subject always to the particular contractual terms agreed upon by the parties.
The Prescription Act 68 of 1969 (“Prescription Act”) sets out the rules governing extinctive prescription. Section 11(d) of the Prescription Act provides that most contractual debts prescribe after three years, while section 12(1) of the Prescription Act stipulates that prescription begins to run only when the “debt is due.”
South African courts have consistently interpreted the phrase “when the debt is due” to mean the point at which a debt is immediately claimable by the creditor and, correlatively, immediately payable by the debtor. As held in cases such as Umgeni Water v Mshengu [2010] 2 All SA
505 (SCA) (“Umgeni Water”) and Van Deventer v Ivory Sun Trading 77 (Pty) Ltd
(“Van Deventer”), a debt can only be said to be “due” when the creditor has a right to institute legal proceedings for its recovery. Until that point, the prescription cannot begin to run.
THE SCA’S FINDINGS
The SCA approached the matter by carefully distinguishing between the existence of a contract and the enforceability of contractual obligations. The SCA cautioned against conflating the date of signature with the date upon which a debt becomes “due” for the purposes of prescription.
The SCA held that even if an agreement is binding from the signature date, rights under a suspensive condition cannot be enforced until the condition is fulfilled. Relying on Van Deventer and Umgeni Water, the SCA reaffirmed that a debt is “due” only once it is immediately claimable. Since TBE could not enforce its rights before 4 June 2009, the prescription could not begin to run before that date. The SCA held that prescription began to run on 4 June 2009. Accordingly, TBE’s summons issued in March 2012 was well within the three-year period.
The decision reaffirms that a prescription cannot begin to run until a debt is “due” in terms of section 12(1) of the Prescription Act, which, in the context of a suspensive condition, is only once the condition has been fulfilled.
From a commercial and practical perspective, the judgment promotes fairness and certainty. If prescriptions were to run from the date of signature, creditors could find their claims prescribed before their rights even became enforceable, an outcome both illogical and unjust. The SCA’s ruling avoids this anomaly and ensures coherence between the doctrines of contract and prescription.
CONCLUSION
The decision in Tight Business Enterprise confirms that, in the context of agreements subject to suspensive conditions, prescription begins to run only from the date on which the suspensive condition is fulfilled. The mere signature of an agreement, while creating a contractual bond, does not trigger prescription as the creditor has no enforceable right at that stage. This judgment underscores the importance of distinguishing between the validity of a contract and the enforceability of rights under such contracts. It also highlights that prescription law serves as a shield against stale claims only once those claims are enforceable in law.
For transactional lawyers, litigators, and commercial clients, the lesson is clear: where suspensive conditions are involved, careful attention must be paid to the date of fulfilment of those conditions, as this is the operative date for purposes of prescription and affects when contractual rights, obligations, and potential disputes come into effect.
Israel Shnketa (LLB (Cum Laude), University of Pretoria & LLM, University of Witwatersrand)
Associate
Mergers and Acquisitions
Get in touch with Israel at:
Telephone Number: 011 243 5071 Email: i.shnketa@tgrattorneys.co.za
